Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT07321873

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Led by Janssen Research & Development, LLC · Updated on 2026-04-13

240

Participants Needed

40

Research Sites

80 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate how well the study drug JNJ-88545223 works compared with a placebo (an inactive substance) in adults with active psoriatic arthritis (PsA). The study aims to see whether treatment with JNJ-88545223 can help reduce the signs and symptoms of PsA and improve joint and skin health.

CONDITIONS

Official Title

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a diagnosis of psoriatic arthritis (PsA) for at least 3 months before the first administration of study intervention and meet classification criteria for Psoriatic Arthritis (CASPAR) at screening
  • Have active PsA defined by at least 3 swollen joints and at least 3 tender joints at screening and baseline
  • Have C-reactive protein (CRP) of 0.1 mg/dL or higher at screening from the central laboratory
  • Have at least one of the following PsA subsets: distal interphalangeal joint involvement, polyarticular arthritis without rheumatoid nodules, asymmetric peripheral arthritis, or spondylitis with peripheral arthritis
  • Have active plaque psoriasis with at least one psoriatic plaque of 2 centimeters or more in diameter or nail changes consistent with psoriasis
  • Female participants of childbearing potential must have negative serum pregnancy test at screening and negative urine pregnancy test at Week 0 prior to intervention
Not Eligible

You will not qualify if you...

  • Have a nonplaque form of psoriasis such as erythrodermic, guttate, or pustular psoriasis
  • Have a history or current signs of severe, progressive, or uncontrolled renal, hepatic, cardiac, vascular, pulmonary, gastrointestinal, endocrine, neurologic, hematologic, rheumatologic (except PsA), psychiatric, genitourinary, or metabolic disorders
  • Have known or suspected allergies, hypersensitivity, or intolerance to JNJ-88545223 or excipients including placebo, or history of severe allergic reaction, angioedema, or anaphylaxis to drugs or food
  • Have fibromyalgia or osteoarthritis symptoms that could interfere with efficacy assessments
  • Currently have a malignancy or a history of malignancy within 5 years before screening

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 40 locations

1

Unity Health-White County Medical Center

Searcy, Arkansas, United States, 72143

Actively Recruiting

2

Newport Huntington Medical Group

Huntington Beach, California, United States, 92648

Actively Recruiting

3

Rheumatology Center of San Diego

San Diego, California, United States, 92128

Actively Recruiting

4

American Research, LLC

Cutler Bay, Florida, United States, 33157

Actively Recruiting

5

Innovation Medical Research Center

Palmetto Bay, Florida, United States, 33157

Actively Recruiting

6

Clinical Research of West Florida

Tampa, Florida, United States, 33606

Actively Recruiting

7

Conquest Research

Winter Park, Florida, United States, 32789

Actively Recruiting

8

Atlanta Research Center for Rheumatology

Marietta, Georgia, United States, 30060

Actively Recruiting

9

Willow Rheumatology and Wellness PLLC

Willowbrook, Illinois, United States, 60527

Actively Recruiting

10

Qualmedica Research

Evansville, Indiana, United States, 47715

Actively Recruiting

11

Joint and Muscle Research Institute

Charlotte, North Carolina, United States, 28204

Actively Recruiting

12

Paramount Medical Research & Consulting

Middleburg Heights, Ohio, United States, 44130

Actively Recruiting

13

Clinical Research Philadelphia

Philadelphia, Pennsylvania, United States, 19114

Actively Recruiting

14

Arthritis and Rheumatology Research Institute

Allen, Texas, United States, 75013

Actively Recruiting

15

Peking University People's Hospital

Beijing, China, 100044

Actively Recruiting

16

Peking University Third Hospital

Beijing, China, 100191

Actively Recruiting

17

Changzhou No 2 Peoples Hospital

Changzhou, China, 213003

Actively Recruiting

18

West China Hospital Sichuan University

Chengdu, China, 610093

Actively Recruiting

19

The Second Affiliated Hospital of Zhejiang University

Hangzhou, China, 310009

Actively Recruiting

20

Ningbo medical center lihuili hospital

Ningbo, China, 315041

Actively Recruiting

21

Hamburger Rheuma Forschungszentrum II

Hamburg, Germany, 20095

Actively Recruiting

22

CAIR Heidelberg

Heidelberg, Germany, 69121

Actively Recruiting

23

Hautarztpraxis Mortazawi

Remscheid, Germany, 42897

Actively Recruiting

24

Hautarztpraxis

Witten, Germany, 58453

Actively Recruiting

25

Imamura General Hospital

Kagoshima, Japan, 890-0064

Actively Recruiting

26

Hospital of the University of Occupational and Environmental Health

Kitakyushu-shi, Japan, 807-8556

Actively Recruiting

27

Osaka Metropolitan University Hospital

Osaka, Japan, 545 8586

Actively Recruiting

28

Sanuki Municipal Hospital

Sanuki, Japan, 769-2393

Actively Recruiting

29

Tokito Clinic Rheumatology and Orthopaedic Surgery

Shimonoseki, Japan, 752 0976

Actively Recruiting

30

Nzoz Osteo Medic

Bialystok, Poland, 15 351

Actively Recruiting

31

Centrum Kliniczno Badawcze

Elblag, Poland, 82-300

Actively Recruiting

32

Malopolskie Badania Kliniczne Sp z o o

Krakow, Poland, 30-002

Actively Recruiting

33

Pratia MCM Krakow

Krakow, Poland, 30-727

Actively Recruiting

34

Etyka Osrodek Badan Klinicznych Tomasz Pesta S K A

Olsztyn, Poland, 10 117

Actively Recruiting

35

MICS Centrum Medyczne Warszawa 1

Warsaw, Poland, 00-872

Actively Recruiting

36

Centrum Medyczne Reuma Park

Warsaw, Poland, 02 665

Actively Recruiting

37

FutureMeds Targowek

Warsaw, Poland, 03 291

Actively Recruiting

38

Hosp Univ A Coruna

A Coruña, Spain, 15006

Actively Recruiting

39

Hosp. Virgen Macarena

Seville, Spain, 41009

Actively Recruiting

40

Hosp. Virgen Del Rocio

Seville, Spain, 41013

Actively Recruiting

Loading map...

Research Team

S

Study Contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis | DecenTrialz